Carbohydrate markers in colon carcinoma

Disease Markers

Volumn 25, Issue 4-5, 2008, Pages 233-242

  Szajda, Sławomir Dariusz ^a   Jankowska, Anna ^a   Zwierz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Carbohydrate markers; Colon carcinoma

Indexed keywords

CADHERIN; CARBOHYDRATE; GLYCOSIDASE; INTEGRIN; MEMBRANE PROTEIN; MUCIN; PROTEOGLYCAN; SELECTIN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER THERAPY; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; COLON; COLON CARCINOMA; COLON POLYP; EPITHELIUM CELL; EUROPE; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; METASTASIS; ONCOGENE; PRIORITY JOURNAL; PROGENY; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 58149400516     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/206510     Document Type: Review

References (79)

1. Y. Ajioka, L.J. Allison and J.R. Jass, Significance of MUC1 and MUC2 mucin expression in colorectal cancer, J Clin Pathol 49 (1996), 560-564.
2. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts and P. Walter, Molecular Biology of the Cell, 4th ed., Garland Science, N.Y., 2002, pp. 1313-1362
3. D. Ayude, M.P. de la Cadena, V.S. Martinez-Zorzano, A. Fernandez-Briera and F.J. Rodrigeuez-Berrocal, Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer, Oncology 64 (2003), 36-45.
4. A.E. Bartman, S.J. Serson, S.L. Ewing, G.A. Niehans, C.L. Wiehr, M.K. Ewans and S.B. Ho, Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps, Int J Cancer 80 (1999), 210-218.
5. A.E. Biemer-Huttmann, M.D. Walsh, M.A. McGuckin, L.A. Simms, J. Young, B.A. Leggett and J.R. Jass, Mucin core protein expression in colorectal cancers with high levels of microsatelite instability indicates a novel pathway of morphogenesis, Clin Cancer Res 6 (2000), 1909-1916.
6. C.R. Boland and G.D. Deshmukh, The carbohydrate composition of mucin in colonic cancer, Gastroenterol 98 (1990), 1170-1177.
7. B.H. Bosmann and T.C. Hall, Enzyme activity in invasive tumors of human breast and colon, Proc Nat Acad Sci USA 71 (1974), 1833-1837.
8. M.G. Brattain, P.M. Kimball and T.G. Pretlow, β-hexosaminidase isoenzymes in human colonic carcinoma, Cancer Res 37 (1977), 731-735.
9. R.S. Bresalier, S.B. Ho, H.L. Schoeppner, Y.S. Kim, M.H. Sleisenger, O. Brodt and J.C. Byrd, Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis, Gastroenterol 110 (1996), 1354-1367.
10. I. Brockhausen, Pathways of O-glycan biosynthesis in cancer cells, Bioch Biophys Acta 1473 (1999), 67-95.
11. R.W. Burt, Colon cancer screening, Gastroenterol 119 (2000), 837-853.
12. J.C. Byrd and R.S. Bresalier, Mucins and mucin binding proteins in colorectal cancer, Cancer Metast Rev 23 (2004), 77-99.
13. J.C. Byrd, L. Sternberg, P. Yan, S.B. Ho and R.S. Bresalier, Ectopic expression of MUC5 gastric mucin in colorectal adenocarcinoma, Gastroenterol 114 (1998), A573.
14. P.M. Calvert and H. Frucht, The genetics of colorectal cancer, Ann Int Med 137 (2002), 603-612.
15. I. Camby, M. Le Mercier, F. Lefranc and R. Kiss, Galectin-1: a small protein with major function, Glycobiology 16 (2006), 137R-157R.
16. C. Capon, C.L. Laboisse, J.M. Wieruszeski, J.J. Maoret, C. Augeron and B. Fournet, Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E, J Biol Chem 267 (1992), 19248-19257.
17. C. Capon, E. Maes, J.C. Michalski, H. Leffler and Y.S. Kim, Sda-antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon, Biochem J 358 (2001), 657-664.
18. A.F. Chambers and L. Matrisian, Changing views of the role of matrix metalloproteinases in metastasis, J Natl Cancer Inst 89 (1997), 1260-1270.
19. A.P. Corfield, N. Myerscough, B.F. Warren, P. Durdey, C. Paraskeva and R. Schauer, Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence, Glycoconj J 16 (1999), 307-317.
20. F. Dall'Olio, M. Chiricolo, C. Cecarelli, F. Minni, D. Marrano and D. Santini, β-galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutin, Int J Cancer 88 (2000), 58-65.
21. M.J. Duffy, CEA as a marker for colorectal cancer: is it clinically useful, Clin Chem 47 (2001), 624-630.
22. M.J. Duffy, A. van Dalen, C. Haglund, L. Hansson, E. Holinski-Feder, R. Klapdor, R. Lamerz, P. Peltomaki Lloyd, C. Sturgeon and O. Topolcan, Tumour markers in colorectal cancer: European group on tumour markers (EGTM) guidelines for clinical use, Eur J Cancer 43 (2007), 1348-1360.
23. M.J. Duffy, A. van Dahlen, C. Haglund, L. Hansson, R. Klapdor, R. Lamerz, O. Nilsson, C. Sturgeon and O. Topolcan, Clinical utility of biochemical markers in colorectal cancer: European group on tumor markers (EGTM) guidelines, Eur J Cancer 39 (2003), 718-727.
24. J. Ferlay, P. Gautier, M. Boniol, M. Heanue, M. Colombet and P. Boyle, Estimates of the cancer incidence and mortality in Europe in 2006, Ann Oncol 18 (2007), 581-592.
25. 1-subunit correlate with invasion and metastasis in colorectal cancer, Cancer Lett 91 (1995), 145-149.
26. M. Garcia, C. Seigner, C. Bastid, R. Choux, M.J. Payan and H. Reggio, Carcinoembryonic antigen has a different molecular weight in normal colon and in cancer cells due to N-glycosylation differences, Cancer Res 51 (1991), 5679-5686.
27. P. Geßner, S. Riedl, A. Quentmaier and W. Kemmner, Enhanced activity of CMP-NeuAc: Galβ1-4GlcNAc:2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients, Cancer Lett 75 (1993), 143-149.
28. R. Giavazzi, M. Foppolo, R. Dossi and A. Remuzzi, Roling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions, J Clin Invest 92 (1993), 3038-3044.
29. E. Gil-Martin, J. Rodriguez-Berrocal, M. Paez de la Cadena and A. Fernandez-Briera, Alterations of glycosidases in human colonic adenocarcinoma, Clin Biochem 30 (1997), 17-25.
30. N. Habal, R.K. Gupta, A.J. Bilchik, T. Johnson and D.L. Morton, TA90-IC, a new marker for advanced colon cancer, Ann Surg Oncol 7 (2000), 352-356.
31. S. Hirohashi, Inactivation of the E-cadherin-mediated cell adhesion system in human cancers, Am J Pathol 153 (1998), 333-339.
32. A. Hittelet, H. Legendre, N. Nagy, Y. Bronckart, J.C. Pector, I. Salmon, P. Yeaton, H.J. Gabius, R. Kiss and I. Camby, Upregulation of galectins-1 and 3 in human colon cancer and their role in regulating cell migration, Int J Cancer 103 (2003), 370-379.
33. M.N. Holten-Andersen, I.J. Christensen, H.J. Nielsen, R.W. Stephens, V. Jensen, O.H. Nielsen, S. Sørensen, J. Overgaard, H. Lilja, A. Harris, G. Murphy and N. Brünner, Total levels of tissue inhibitor of metalloproteinase 1 in plasma yield high diagnostic sensitivity and specificity in patients with colorectal cancer, Clin Cancer Res 8 (2002), 156-164.
34. M.N. Holten-Andresen, R.W. Stephens, H.J. Nielsen, G. Murphy, I.J. Christensen, W. Stetler-Stevenson and N. Brünner, High preoperative plasma tissue inhibitor of metalloproteinase 1 are associated with short survival of patients with colorectal cancer, Clin Cancer Res 6 (2000), 4292-4299.
35. R.O. Hynes, Integrins: versality, modulation, signaling in cell adhesion, Cell 69 (1992), 11-25.
36. F. Inomata, A. Ochiai, K. Sugihara, Y. Moria, N. Yamahuchi, Y. Adach, S. Kitano and S. Hirohashi, Macroscopic features at the deepest site of tumor penetration predicting liver metastases of colorectal cancer, Jpn Clin Oncol 28 (1998), 123-128.
37. H. Inufusa, M. Nakamura, T. Adachi, M. Aga, M. Kurimoto, Y. Nakatani, T. Wakano, M. Miyake, K. Okuno, H. Shiozaki and M. Yasutomi, Role of galectin -3 in adenocarcinoma liver metastasis, Int J Oncol 19 (2001), 913-919.
38. S.H. Itzkowitz, E.J. Bloom, W.A. Kokal, G. Modin, S. Hakomori and Y.S. Kim, Sialosyl Tn, a novel mucin antigen associated with prognosis in colorectal cancer patients, Cancer 66 (1990), 1960-1966.
39. S.H. Itzkowitz, R. Dahiya, J.C. Byrd and Y.S. Kim, Blood group antigen synthesis and degradation in normal and cancerous colonic tissues, Gastroenterol 99 (1990), 431-442.
40. S.H. Itzkowitz, E. Young, D. Dubois, N. Harpaz, C. Bodian, A. Chen and D.B. Sachar, Sialosyl-Tn is prevalent and precedes dysplasia in ulcerative colitis: A retrospective case-control study, Gastroenterol 110 (1996), 694-704.
41. S.H. Itzkowitz, M. Yuan, C.K. Mongomery, T. Kjeldsen, H.K. Tskahashi, W.L. Bigbee and Y.S. Kim, Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer, Cancer Res 49 (1989), 197-204.
42. P.M. Kimball, M.G. Brattain and W.E. White, Characterization of an unusual isoenzyme of N-acetyl-β-D-hexosaminidase from a human colonic carcinoma cell line, Biochem J 193 (1981), 109-113.
43. B. Kocer, A. Soran, S. Erdogan, M. Karabeyoglu, O. Yildirim, A. Eroglu, B. Bozkurt and O. Cengiz, Expression of MUC5AC in colorectal carcinoma and relationship with prognosis, Pathol Int 52 (2002), 470-477.
44. 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastasis, Am J Pathol 138 (1991), 741-750.
45. B.V. Lampe, A. Stallmach and E.O. Riecken, Altered glycosylation of integrin adhesion molecules of the human fibronectin receptor, J Biol Chem 264 (1993), 18011-18018.
46. K.O. Lloyd, The chemistry and immunochemistry of blood group A, B, H and Lewis antigens: Past, present and future, Glycoconj 17 (2000), 531-541.
47. R.J. Longman, J. Douthwaite, P.A. Sylvester, D. O'Leary, B.F. Waren, A.P. Corfield and M.G. Thomas, Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas, J Clin Pathol 53 (2000), 100-104.
48. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, L.M. Schuman and F. Ederer, Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N Engl J Med 328 (1993), 1365-1371.
49. K. Matsuda, T. Masaki, T. Watanabe, J. Kitayama, H. Nagawa, T. Muto and Y. Ajioka, Clinical significance of MUC1 and MUC2 and p53 protein expression in colorectal carcinoma, Jpn J Clin Oncol 30 (2000), 89-94.
50. A. Merino-Trigo, F.J. Rodriguez-Berrocal, E. de Miguel and M.P. de la Cadena, Activity and properties of α-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells, Int J Biochem Cell Biol 34 (2002), 1291-1303.
51. C. Muir and J. Waterhouse, Comparability and quality of data: Reliability of registration, in: Cancer Incidence in Five Continents, Volume V, C. Muir, J. Waterhouse, T. Mack et al., eds, IARC scientific publication No. 88, Lyon, France, International Agency for Research on Cancer, 1987, pp. 45-169
52. N. Nagy, H. Legendre, O. Engels, S. Andre, H. Kaltner, K. Wasano, Y. Zick, J.C. Pector, C. Decaestecker, H.J. Gabius, I. Salmon and R. Kiss, Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting, Cancer 97 (2003), 1849-1858.
53. S. Nakomori, D.M. Ota, K.R. Cleary, K. Shirotani and T. Irimura, MUC1 mucin expression as a marker of progression and metastasis of human colorectal cancer, Gastroenterol 106 (1994), 353-361.
54. NCCN Clinical Practice Guidelines in Oncology: Colorectal Cancer Screening 1v, 2006.
55. F.B. Nicholson, J.L. Barro, W. Atkin, R. Lilford, J. Patnick, C.B. Williams, M. Pignone, R. Steele and M.A. Kamm, Review article: population screening for colorectal cancer, Aliment Pharmacol Ther 22 (2005), 1069-1077.
56. J.B. O'Connel, M.A. Maggard and C.Y. Ko, Colon cancer survival rates with the staging American Joint Committee on cancer, sixth edition, J Natl Cancer Inst 96 (2004), 1420-1425.
57. S. Ogata, H. Uehara, A. Chen and S.H. Itzkowitz, Mucin gene expression in colonic tissues and cell lines, Cancer Res 52 (1992), 5971-5978.
58. S. Oikawa, H. Nakazato and G. Kosaki, Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence, Biochem Biophys Res Communs 142 (1987), 511-518.
59. M. Ono, M. Sakamoto, Y. Ino, Y. Moriya, K. Sugihara, T. Muto and S. Hirohashi, Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis, Cancer 78 (1996), 1179-1186.
60. F. Pages, A. Berger,M. Camus, F. Sanchez-Cabo, A. Costes, R. Molidor, B. Mlecnik, A. Kirilovsky, M. Nilsson, D. Damotte, T. Meatchi, P. Bruneval, P-H. Cugnenc, Z. Trajanoski, WH. Friedman and J. Galon, Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med 353 (2005), 2654-2666.
61. H.S. Panda, J. Waxman and K. Sikora, Tumour markers, Brit J Hosp Med 51 (1994), 297-303.
62. K.D. Pant and J.D. McCracken, Noninvasive colorectal cancer screening, Dig Dis Sci 47 (2002), 1236-1240.
63. M.C. Plucinsky, J.J. Prorok and J.A. Alhadeff, Beta-hexosaminidase from colon and sera of dukes-classified colorectal cancer patients: activity levels, isoenzyme patterns, and kinetic properties, J Natl Cancer Inst 77 (1986), 57-62.
64. J.W. Pollard, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer 4 (2004), 71-78.
65. I.T. Said, A.M. Shamsuddin, M.A. Sherief, S.G. Taleb, W.F. Aref and D. Kumar, Comparison of different techniques for detection of Gal-GAlNAc, an early marker of colonic neoplasia, Histol Histopathol 14 (1999), 351-357.
66. O. Saitoh, W.C. Wang, R. Lotan and M. Fukuda, Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials, J Biol Chem 267 (1992), 5700-5711.
67. K. Schulmann, M. Reiser and W. Schmiegel, Colonic cancer and polyps, Best Pract Res Clin Gastroenterol 16(1) (2002), 91-114.
68. Senate Resolution 108, Designation of National Colorectal Cancer Awareness Month (http://www.cdc.gov.cancer/ colorctl/sres108.htm.
69. T. Shibata, A. Ochiai, Y. Kanai, S. Akimoto, M. Gotoh, N. Yasui, R. Machinami and S. Hirohashi, Dominant negative inhibition of the association between β-catenin and c-erbB-2 by N-terminally deleted β-catenin suppresses the invasion and metastasis of cancer cells, Oncogene 13 (1998), 883-889.
70. W. Sulowicz, Activity of some lysosomal enzymes in neutrophils from peripheral blood of patients with digestive tract cancer at different clinical stages of the disease. A cytochemical study, Rev Esp Oncol 28 (1981), 509-514.
71. S.D. Szajda, J. Snarska, M. Borzym-Kluczyk, B. Zalewska, N. Waszkiewicz, M. Bierć and K. Zwierz, Activity of β-galactosidase and α-mannosidase in the serum of patients with colon adenocarcinoma, Contemporary Oncology 11 (2007), 64-66.
72. S.D. Szajda, J. Snarska, Z. Puchalski and K. Zwierz, Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma. Hepatogastroenterology 84 (2008), 921-925.
73. M. Takeichi, Cadherin cell adhesion receptors as a morphogenetic regulator, Science 251 (1991), 1451-1455.
74. J. Weitz, M. Koch, J. Debus, T. Hohler, P.R. Galle and M.W. Buchler, Colorectal cancer, Lancet 365 (2005), 153-165.
75. M.S. Wide? and M. Wide?, Mechanisms of metastasis and molecular markers of malignant tumor progression, I, Colorectal cancer, Post Hig Med Dosw 60 (2006), 453-470.
76. S.J. Williams, M.A. McGuckin, D.C. Gotley, H.J. Eyre, G.R. Sutherland and T.M. Antalis, Two novel mucin genes down-regulated in colorectal cancer identified by differential display, Cancer Res 59 (1999), 4083-4089.
77. A. Velcich, J. Heyer, A. Fragale, C. Nicholas, S. Viani, R. Kucherpati, M. Lipkin, K. Yang and L. Augenlicht, Colorectal cancer in mice genetically deficient in the mucin MUC2, Science (2002), 1726-1729.
78. A. Zalewska, K. Zwierz, K. Żókowski and A. Gindzieński, Structure and biosynthesis of human salivary mucins, Acta Biochim Pol 47 (2000), 1067-1079.
79. M. Yuan, S.H. Itzkowitz, C.R. Boland, Y.D. Kim, J.T. Tomita, A. Palekar, J.L. Bennington, B.F. Trump and Y.S. Kim, Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry, Cancer Res 46 (1986), 4841-4847.